Contact this trialFirst, we need to learn more about you.
Antibody-drug Conjugate
Sacituzumab Govitecan for Endometrial Cancer
Recruiting2 awardsPhase 3
Saint Louis Park, Minnesota
This trial aims to understand how a drug called sacituzumab govitecan (SG) works in patients with endometrial cancer who have already been treated with platinum-based chemotherapy and immunotherapy
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service